Polar Capital Holdings PLC Deciphera Pharmaceuticals, Inc. Transaction History

Polar Capital Holdings PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $4.75 Million - $6.08 Million	-350,000 Reduced 18.92%	1,500,000 $23.6 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $1.01 Million - $1.65 Million	100,000 Added 5.71%	1,850,000 $29.8 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $7.13 Million - $11.1 Million	500,000 Added 40.0%	1,750,000 $27 Million
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $3.1 Million - $5.06 Million	-250,000 Reduced 16.67%	1,250,000 $23.1 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $13.7 Million - $21 Million	1,500,000 New	1,500,000 $19.7 Million
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $1.12 Million - $1.81 Million	-163,100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $3.08 Million - $14.9 Million	-400,000 Reduced 71.04%	163,100 $1.59 Million
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $4.32 Million - $6.06 Million	163,100 Added 40.78%	563,100 $19.1 Million
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $2.02 Million - $2.84 Million	50,000 Added 14.29%	400,000 $17.9 Million
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $18.1 Million - $23.2 Million	350,000 New	350,000 $20 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.